Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vectus Biosystems Limited ( (AU:VBS) ) has shared an update.
Vectus Biosystems Limited has released its Corporate Governance Statement for the period from July 2024 to June 2025, highlighting its adherence to ASX corporate governance principles. The company acknowledges that while it strives to comply with these guidelines, certain recommendations are not feasible due to its size. The Board, supported by various committees, oversees governance, ensuring transparency and accountability in its operations.
More about Vectus Biosystems Limited
Vectus Biosystems Limited operates in the biotechnology industry, focusing on the development of therapeutic products. The company is committed to adhering to corporate governance principles, guided by the Australian Securities Exchange’s recommendations.
Average Trading Volume: 54,692
Technical Sentiment Signal: Sell
Current Market Cap: A$3.2M
Learn more about VBS stock on TipRanks’ Stock Analysis page.